Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
Cardiovascular disease (CVD) is one of the most severe diseases in clinics. Fibroblast growth factor 21 (FGF21) is regarded as an important metabolic regulator playing a therapeutic role in diabetes and its complications. The heart is a key target as well as a source of FGF21 which is involved in he...
Main Authors: | Cheng, Peng, Zhang, Fangfang, Yu, Lechu, Lin, Xiufei, He, Luqing, Li, Xiaokun, Lu, Xuemian, Yan, Xiaoqing, Tan, Yi, Zhang, Chi |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876232/ |
Similar Items
-
Low‐dose radiation prevents type 1 diabetes‐induced cardiomyopathy via activation of AKT mediated anti‐apoptotic and anti‐oxidant effects
by: Zhang, Fangfang, et al.
Published: (2016) -
Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation
by: Zhang, Chi, et al.
Published: (2013) -
FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation
by: Yan, Xiaoqing, et al.
Published: (2015) -
Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice
by: Yan, Xiaoqing, et al.
Published: (2015) -
A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol
by: Huang, Zhifeng, et al.
Published: (2011)